These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 6292419

  • 21. Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by flavonoids. III.
    Nikaido T, Ohmoto T, Kinoshita T, Sankawa U, Delle Monache F, Botta B, Tomimori T, Miyaichi Y, Shirataki Y, Yokoe I.
    Chem Pharm Bull (Tokyo); 1989 May; 37(5):1392-5. PubMed ID: 2560949
    [Abstract] [Full Text] [Related]

  • 22. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.
    Lugnier C, Schoeffter P, Le Bec A, Strouthou E, Stoclet JC.
    Biochem Pharmacol; 1986 May 15; 35(10):1743-51. PubMed ID: 2423089
    [Abstract] [Full Text] [Related]

  • 23. Isolation of similar rolipram-inhibitable cyclic-AMP-specific phosphodiesterases from rat brain and heart.
    Némoz G, Moueqqit M, Prigent AF, Pacheco H.
    Eur J Biochem; 1989 Oct 01; 184(3):511-20. PubMed ID: 2553394
    [Abstract] [Full Text] [Related]

  • 24. Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices.
    Whalin ME, Garrett RL, Thompson WJ, Strada SJ.
    Second Messengers Phosphoproteins; 1989 Oct 01; 12(5-6):311-25. PubMed ID: 2856115
    [Abstract] [Full Text] [Related]

  • 25. 7-Bromo-1,5-dihydro-3,6-dimethylimidazo[2,1-b]quinazolin-2(3H)- one (Ro 15-2041), a potent antithrombotic agent that selectively inhibits platelet cyclic AMP-phosphodiesterase.
    Muggli R, Tschopp TB, Mittelholzer E, Baumgartner HR.
    J Pharmacol Exp Ther; 1985 Oct 01; 235(1):212-9. PubMed ID: 2995647
    [Abstract] [Full Text] [Related]

  • 26. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ, Cieslinski LB.
    Mol Pharmacol; 1990 Feb 01; 37(2):206-14. PubMed ID: 2154670
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by flavonoids from licorice roots and 4-arylcoumarins.
    Kusano A, Nikaido T, Kuge T, Ohmoto T, Delle Monache G, Botta B, Botta M, Saitoh T.
    Chem Pharm Bull (Tokyo); 1991 Apr 01; 39(4):930-3. PubMed ID: 1654220
    [Abstract] [Full Text] [Related]

  • 28. Quantitative structure-activity relationships for the inhibition of heart and brain cyclic AMP phosphodiesterases by some phenylbutenolides.
    Duperray B, Nemoz G, Prigent AF, Pacheco H.
    Biochem Pharmacol; 1980 Jan 01; 29(1):115-8. PubMed ID: 6244825
    [No Abstract] [Full Text] [Related]

  • 29. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
    Price B, Pyne NJ, Houslay MD.
    Biochem Pharmacol; 1987 Dec 01; 36(23):4047-54. PubMed ID: 2825712
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Flavonoids are selective cyclic GMP phosphodiesterase inhibitors.
    Ruckstuhl M, Beretz A, Anton R, Landry Y.
    Biochem Pharmacol; 1979 Dec 01; 28(4):535-8. PubMed ID: 218594
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Silymarin: potent inhibitor of cyclic AMP phosphodiesterase.
    Koch HP, Bachner J, Löffler E.
    Methods Find Exp Clin Pharmacol; 1985 Aug 01; 7(8):409-13. PubMed ID: 3001454
    [Abstract] [Full Text] [Related]

  • 35. 8-phenyltheophylline as an inhibitor of cyclic AMP hydrolysis by cyclic nucleotide phosphodiesterase.
    Nicholson CD, Wilke R.
    J Auton Pharmacol; 1989 Jun 01; 9(3):159-65. PubMed ID: 2545716
    [Abstract] [Full Text] [Related]

  • 36. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
    Elks ML, Manganiello VC.
    Endocrinology; 1984 Oct 01; 115(4):1262-8. PubMed ID: 6207009
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain.
    Levin RM, Weiss B.
    Mol Pharmacol; 1976 Jul 01; 12(4):581-9. PubMed ID: 183095
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cyclic nucleotide phosphodiesterase in rat neostriatum: properties of the enzyme in crude homogenates.
    Minneman KP.
    J Neurochem; 1976 Nov 01; 27(5):1173-80. PubMed ID: 12170604
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.